Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.
ML Brown, F Houn, EA Sickles… - AJR. American journal …, 1995 - Am Roentgen Ray Soc
The purpose of this study was to gather from 50 community mammography practices that
were included in the National Survey of Mammography Facilities data concerning abnormal …
were included in the National Survey of Mammography Facilities data concerning abnormal …
Screening mammography: clinical image quality and the risk of interval breast cancer
…, C Finder, MT Mandelson, F Houn… - American Journal of …, 2002 - Am Roentgen Ray Soc
OBJECTIVE. We evaluated the association between clinical image quality and breast cancer
occurrence within 24 months of a negative mammogram. MATERIALS AND METHODS. We …
occurrence within 24 months of a negative mammogram. MATERIALS AND METHODS. We …
Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue
…, E Leutzinger, DA Place, EP Duffy, F Houn… - … of pharmaceutical and …, 2008 - Elsevier
Ferric hexacyanoferrate (Fe 4 III [Fe II (CN) 6 ] 3 ), also known as insoluble Prussian blue (PB)
is the active pharmaceutical ingredient (API) of the drug product, Radiogardase ® . …
is the active pharmaceutical ingredient (API) of the drug product, Radiogardase ® . …
Predictors of and satisfaction with bilateral prophylactic mastectomy
ME Stefanek, KJ Helzlsouer, PM Wilcox, F Houn - Preventive medicine, 1995 - Elsevier
Background. Women with a first-degree relative with breast cancer are at increased risk of
developing this disease. The optimal medical management of these women is unclear, with …
developing this disease. The optimal medical management of these women is unclear, with …
Quantitative measurement of cyanide released from Prussian Blue
…, D Place, E Leutzinger, E Duffy, R He, F Houn… - Clinical …, 2007 - Taylor & Francis
Background. Prussian Blue (PB), ferric hexacyanoferrate is indicated for (oral) treatment of
internal contamination with radioisotopes of cesium or thallium. Cyanide is 35–40% of PB's …
internal contamination with radioisotopes of cesium or thallium. Cyanide is 35–40% of PB's …
[HTML][HTML] Effectiveness of risk evaluation and mitigation strategies (REMS) for lenalidomide and thalidomide: patient comprehension and knowledge retention
NA Brandenburg, R Bwire, J Freeman, F Houn… - Drug safety, 2017 - Springer
Introduction The effectiveness of patient education activities conducted within the
lenalidomide and thalidomide risk evaluation and mitigation strategies (REMS) programs was …
lenalidomide and thalidomide risk evaluation and mitigation strategies (REMS) programs was …
Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective
R Bwire, J Freeman, F Houn - Expert Opinion on Drug Safety, 2011 - Taylor & Francis
Celgene has developed and operated pregnancy prevention programs since 1998 with the
first approval of thalidomide in the US. With the development and marketing of lenalidomide, …
first approval of thalidomide in the US. With the development and marketing of lenalidomide, …
Mammography in the 1990s: the United States and Canada
…, DC Spelic, JL McCrohan, GR Symonds, F Houn - Radiology, 1999 - pubs.rsna.org
PURPOSE: To evaluate trends in mammography quality before and after the implementation
of the Mammography Quality Standards Act (MQSA) of 1992 and to compare technical data …
of the Mammography Quality Standards Act (MQSA) of 1992 and to compare technical data …
The association between alcohol and breast cancer: popular press coverage of research.
F Houn, MA Bober, EE Huerta… - … journal of public …, 1995 - ajph.aphapublications.org
OBJECTIVES. This study was undertaken to examine popular press reports of the association
between alcohol and breast cancer. METHODS. Articles from scientific journals and …
between alcohol and breast cancer. METHODS. Articles from scientific journals and …
The practice of prophylactic mastectomy: a survey of Maryland surgeons.
F Houn, KJ Helzlsouer… - … journal of public …, 1995 - ajph.aphapublications.org
OBJECTIVES. Bilateral prophylactic mastectomy is a drastic breast cancer preventive option
for which indications are not standardized and efficacy has not been proven. To estimate …
for which indications are not standardized and efficacy has not been proven. To estimate …